Senior insider sale
CHIEF EXECUTIVE OFFICER at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$13.4K
5.69K shares
What this filing means
LENNON DAVID JAMES plans to sell 5.69K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $13.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2025ACC: 0001786205-25-000024
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
5.69K
Shares to sell
$13.4K
Approx. market value
16.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2025
16.25KTotal acquired16.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted Stock Units N/A | 16.25K | — |
| Total | 16.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.69K
Market value
$13.4K
3/3/2025
Total
Units
5.69K
Value
$13.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/3/2025 | 5.69K | $13.4K | NASDAQ | Planned |
| Total | 5.69K | $13.4K | ||